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Abstract
Background: Mass spectrometric analysis of peptides is an essential part of protein identification
and characterization, the latter meaning the identification of modifications and amino acid
substitutions. There are two main approaches for characterization: (i) using a predefined set of
possible modifications and substitutions or (ii) performing a blind search. The first option is
straightforward, but can not detect modifications or substitutions outside the predefined set. A
blind search does not have this limitation, and therefore has the potential of detecting both known
and unknown modifications and substitutions. Combining the peptide mass fingerprints from two
proteases result in overlapping sequence coverage of the protein, thereby offering alternative views
of the protein and a novel way of indicating post-translational modifications and amino acid
substitutions.
Results: We have developed an algorithm and a software tool, MassShiftFinder, that performs a
blind search using peptide mass fingerprints from two proteases with different cleavage specificities.
The algorithm is based on equal mass shifts for overlapping peptides from the two proteases used,
and can indicate both post-translational modifications and amino acid substitutions. In most cases
it is possible to suggest a restricted area within the overlapping peptides where the mass shift can
occur. The program is available at http://www.bioinfo.no/software/massShiftFinder.
Conclusion: Without any prior assumptions on their presence the described algorithm is able to
indicate post-translational modifications or amino acid substitutions in MALDI-TOF experiments
on identified proteins, and can thereby direct the involved peptides to subsequent TOF-TOF
analysis. The algorithm is designed for detailed and low-throughput characterization of single
proteins.
Background
The detection and verification of post-translational modi-
fications in proteins and peptides by mass spectrometry
(MS) is a common technique in protein characterization.
The protein is proteolytically cleaved into peptides and
analyzed by MS. MALDI-TOF instruments generate a list
of mass-over-charge ratios (m/z values), referred to as a
peptide mass fingerprint (PMF), which is compared to
theoretical PMFs of known proteins. Modifications can be
included in the theoretical PMFs. However, including too
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few can result in undetected modifications, while select-
ing too many can result in wrongly suggested modifica-
tions. One option is to perform the search in two
iterations, where first a few expected modifications are
considered. Thereafter, unmatched peptides are submit-
ted to a modification search, e.g., in FindMod [1] or Mass-
Sorter [2]. FindMod only considers 22 common
modifications. Here we present an alternative approach
using blind search, where PMF data from two proteases on
two aliquots of a sample are used to indicate modifica-
tions and amino acid substitutions. If the same mass shift
relative to the unmodified theoretical values is observed
for both proteases, and the peptides are overlapping, the
mass shift can correspond to a modification or a substitu-
tion. MacCoss et al. [3] used a similar reasoning, but only
to verify a limited set of predefined modifications in LC-
MS/MS experiments. Unrestricted search for modifica-
tions using LC-MS/MS data has been developed more
recently [4,5].
Figure 1 shows two overlapping peptides, p1 and p2, gen-
erated by different proteases. Let p1 be the most N-termi-
nal peptide, and p2 the most C-terminal peptide. The
overlapping peptides define three areas: the overlapping
area, Y; the area of p1 not overlapping with p2, X (N-termi-
nal area); and the area of p2 not overlapping with p1, Z (C-
terminal area). Together, these will be referred to as the
covered area. Note that p1 and p2 may have the same start
or end residue, or that one peptide can completely cover
the other. The main idea for our method is that a modifi-
cation or an amino acid substitution occurring in area Y
can be detected as an equal mass shift in p1 and p2. Equal
mass shifts occurring in X and Z, but not in Y, can also be
detected. This means that the non-overlapping areas X
and Z both contain the same modified amino acid, or dif-
ferent amino acids carrying an identical modification, e.g.,
phosphorylation on S and T.
Let (i) p1 and p2 be two overlapping theoretical peptides;
(ii) t1 be the theoretical mass of p1, and t2 be the theoreti-
cal mass of p2; and (iii) e1 be an experimental mass using
protease A, and e2 be an experimental mass using protease
B. Suppose the following equation is observed: e1 - t1 = e2
- t2 = Δm. Δm is then either a real mass shift or an artifact.
Real mass shifts: e1 corresponds to p1, and e2 corresponds to
p2. The mass shift can then (i) occur solely in Y; (ii) occur
in both X and Z; or (iii) the mass shifts occur as a combi-
nation of the two former cases. In the first case, the mass
shift can correspond to one or more modifications/substi-
tutions, while in the other cases, two or more modifica-
tions are needed.
Artifact: at least one of the masses e1 or e2 does not corre-
spond to p1 or p2 respectively. Artifacts are covered in
more detail in the Discussion.
Findings
Algorithm
The following algorithm detects equal mass shifts in over-
lapping peptides:
1. Let E1 be the peptide mass list from an experiment using
protease A, and E2 be the peptide mass list from an exper-
iments using protease B.
2. Let T1 be the list of theoretical peptide masses resulting
from an in silico digestion using protease A, and T2 be the
list of theoretical peptide masses resulting from an in sil-
ico digestion using protease B.
3. Remove from E1 all peaks corresponding to unmodified
peptides in T1 and all peaks corresponding to autolytic
peaks from protease A.
4. Repeat Step 3 with mass lists E2 and T2 from protease B.
5. Compare each mass ei ∈ E1 to each mass tj ∈ T1, and
each mass ek ∈ E2 to each mass tm ∈ T2. Store the mass
shifts (ei - tj) for all i and j and the mass shifts (ek - tm) for
all k and m, in two lists M1 and M2, which now contain all
possible mass shifts between corresponding experimental
and theoretical data.
6. Let pj and pm be the theoretical peptides corresponding
to tj and tm respectively. Compare M1 and M2 and find all
pairs such that:
a. |(ei - tj) - (ek - tm)| = ω and (ω is the mass shift accuracy)
Overlapping peptides Figure 1
Overlapping peptides. The peptides p1 and p2 define dif-
ferent regions (X, Y, Z) of the covered area as explained in 
the text. The figure also indicates that if adjacent peptides p3 
and p4 are found, they can be combined with p2 and p1, 
respectively, to strengthen the probability for found mass 
shifts in X or Z being real mass shifts.
p1  p3 
X Y Z
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b. |(ei - tj)| > ε and |(ek - tm)| > ε and (ε is the mass shift
threshold)
c. pj and pm overlap
The output is a list of overlapping peptides from E1 and E2
with equal mass shifts. The reason for the mass shifts, i.e.,
modification(s) or substitution(s), has to be positioned in
the covered area, and have a mass equal to the detected
mass shift. The list should be cross-checked against a data-
base of known modifications and substitutions (e.g., Uni-
Mod [6,7]), and/or the included peptides can be tested in
additional experiments, i.e., by MALDI-TOF-TOF, verify-
ing or rejecting the proposed modification or substitu-
tion.
Implementation
The described algorithm is implemented in Java [8] and
available as a software tool, MassShiftFinder, at http://
www.bioinfo.no/software/massShiftFinder.
The main input to MassShiftFinder is the protein
sequence and the experimental masses from two PMF
experiments on the same protein using different pro-
teases. Before running the algorithm it is recommended to
remove all identified peptides from the PMFs, e.g., by
using MassSorter [2]. Unmodified peptides, autolytic pro-
tease peaks and known noise/contaminating peaks (e.g.,
keratin) can be filtered within adjustable accuracy limits
in the program. Using filters limits the number of unnec-
essary mass shift comparisons (see additional file 1, Fig. 1
(TheoreticalExamples.pdf)).
In order to reduce search space and increase the possibility
of detecting real mass shifts, the following parameters
should be set to reasonable values. (i) Mass Shift Thresh-
old, where mass shifts below this threshold are excluded
to avoid spurious comparisons among very small mass
shifts. We would in general recommend setting this value
to 0.9 to achieve the inclusion of deamidations. (ii) Mass
Shift Boundaries, determine the search limits for a mass
shift being a modification or substitution. It can be set to
a more limited mass range, e.g., 79–81 Da to search for
phosphorylations. (iii) Mass Shift Accuracy, where equal
mass shifts are recognized when the difference between
two mass shifts are within this accuracy (in Da or ppm).
We would in general recommend setting this parameter at
0.2 Da when 25 ppm accuracy limit is used for the exper-
imental peptides, and to decrease it if the instrument is
more exact. Note that this parameter refers to inaccuracy
of the potential modification as calculated from the com-
parison of experimental data and the theoretical peptide
sequence.
An example of output is shown in Figure 2. By selecting a
row, the overlapping peptides are indicated in the protein
sequence. The detected mass shifts are searched against a
local version of the UniMod database. To reduce the
amount of incorrect UniMod explanations, this search can
be restricted by choosing the allowed modification types,
e.g., amino acid substitutions, post-translational modifi-
cations, etc. Up to two modifications per peptide are sup-
ported. Note that changing the settings for the UniMod
search only affects the number of suggested explanations
for each mass shift, not the number of mass shifts. Unex-
plained mass shifts may correspond to unknown modifi-
cations or more than two modifications per peptide. An
example showing detection of modifications in an artifi-
cial dataset is found in additional file 1 (TheoreticalExam-
ples.pdf).
Experimental Example
We compared connexin43 (Cx43) [9] from three species.
The experimental peak lists of Cx43 from Syrian hamster,
Chinese hamster and rat were collected in MassSorter [2]
using the Syrian hamster sequence as basis of comparison
[10]. After removing autolytic protease peaks, peaks from
the contaminating antibody and peaks in common with
Syrian hamster, the remaining peaks were inserted into
MassShiftFinder using the following parameters: Filter
Accuracy and Unmodified Peptide Accuracy, 50 ppm
(found under Edit/Preferences); Mass Shift Accuracy, 0.2
Da; Mass Shift Threshold, 0.9 Da; Mass Shift Boundaries,
-200 to 200 Da; UniMod Accuracy, 0.1 Da; Missed Cleav-
ages, 1; and including only amino acid substitutions in
the search.
For Chinese hamster, MassShiftFinder pointed out a
potential substitution within the area 347-IAAGHELQPL-
356 with a mass shift of 17.96 Da. This would correspond
to a substitution from I or L to M. The rat data also indi-
cated a potential substitution in the same sequence with a
mass shift of -14.02 Da. This could correspond to a substi-
tution from A to G, E to D, or I or L to V. The Chinese ham-
ster and rat peptides with m/z 1748.91 and m/z 1716.84
(corresponding to mass shifts of 17.95 Da and -14.02 Da
relative to the Syrian hamster peptide with m/z 1730.96)
were targeted for TOF-TOF analysis (Fig. 3). The only pos-
sible substitution in Chinese hamster that is consistent
with all data is a change in position 347 from I (Syrian
hamster) to M (Chinese hamster). For rat, both I347 to V
and A348 to G are consistent with these data. The former
is the correct alternative. This example shows that our
approach can be used to narrow the range of possibilities
when detecting amino acid substitutions. For more exam-
ples and details, see additional file 2 (ExperimentalExam-
ples.pdf).BMC Research Notes 2008, 1:130 http://www.biomedcentral.com/1756-0500/1/130
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Discussion
The algorithm depends on good experimental sequence
coverage and overlapping peptides. Sequence coverage
mainly depends on the amino acid sequence, the sample
amount, the protease used, and purity. An analysis of
human proteins in SwissProt suggests that approximately
70–90% of the proteins have a theoretical coverage
between 50 and 100%, regardless of whether trypsin, chy-
motrypsin or gluC was used (see additional file 3: Supple-
mentaryMaterials.pdf). The experimental sequence
coverage is usually lower than the theoretical upper limit,
but a considerable degree of experimental overlap would
generally be expected.
A detected mass shift (Δm) can either be real, i.e., resulting
from a modification/substitution, or an artifact. Although
unknown modifications still can be found [4], it is more
likely that a mass shift is due to a known modification.
Following the parsimony principle, it seems reasonable to
first assume that a mass shift is caused by a single known
modification. Accepted modified peptides can then be
removed before subsequent searches are performed with
less restricted parameters, e.g., allowing two modifica-
tions per peptide.
The tendency for artifacts is augmented by the clustering
of peptide masses [11-15] and the fact that most modifi-
cation masses also are close to integers. In the mass range
Screenshot of the MassShiftFinder main window Figure 2
Screenshot of the MassShiftFinder main window. The data are taken from an experiment on guanidinated enolase (see 
additional file 2: ExperimentalExamples.pdf). The mass shift boundaries are set to restrict the detected mass shift mainly to gua-
nidinations (mass shift of 42 Da). The highlighted row (14) indicates an "X-Z" mass shift (see Figure 1). Rows 11–13 show a 
mass shift occurring in the Y-area, with one tryptic peptide (1316.7) paring up with three chymotryptic peptides. The right-
most column (UniMod hits) for most of the rows indicates that there are three modifications (acetylation, tri-methylation and 
guanidination) that are consistent with a mass shift of 42 for the indicated peptides. Row 16 has 0 UniMod hits because the cal-
culated mass shift is more than 0.1 Da from the three mentioned modifications; furthermore, this mass shift cannot be due to 
guanidinated K as only one of the peptides contains a K.BMC Research Notes 2008, 1:130 http://www.biomedcentral.com/1756-0500/1/130
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from 1 to 100 Da, approximately 75% of all integers have
one or several modifications/substitutions with a mass
close to it [6,7]. This means that at any random, but near-
integer, distance from the true peptide m/z value, there is
a considerable chance that one or several modifications
will fit to this integer value. Furthermore, any positive
near-integer value between 2 and 100 can be achieved by
a combination of two modifications in the peptide. Thus,
as the number of non-identified peptides increases, the
likelihood of finding artifacts also increases.
In characterization high sequence coverage is desired, and
one might therefore use as many peaks as possible,
including low intensity peaks that would not have been
used for identification purposes. Such peaks are more
influenced by random noise, and are in general expected
to have lower accuracy than high intensity peaks. Proteo-
lytic cleavage specificity and efficiency are also not perfect.
Thus, several factors will contribute to artifacts. A main
strategy is to remove all peptides that can be identified
with reasonable confidence before the initial mass shift
comparison is performed. It is also recommended to
search for peptides with unexpected cleavages or many
missed cleavages by using MassSorter [2], FindPept [16]
or similar tools, especially if an "unreliable" protease (like
chymotrypsin) has been used.
Our primary objective with the algorithm is to promote
the detailed low-throughput characterization of single
proteins by indicating peptides that may contain modifi-
TOF-TOF data of the Cx43 peaks at m/z 1716.84 and m/z 1748.91 Figure 3
TOF-TOF data of the Cx43 peaks at m/z 1716.84 and m/z 1748.91. The peptides 1716.84 (upper) and 1748.91 (lower) 
are from rat and Chinese hamster Cx43, respectively. Note that the y2-ion at m/z 303.2 had higher intensity than all other ions. 
In both panels, the upper sequence is read from the b-ions, and the lower sequence is read from the y-ions. Further note that 
also the a5- to a8-ions can be distinguished in the upper panel, and the a5- and a6-ions in the lower panel. See text for more 
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cations or substitutions. This can help in selecting peaks
to target in fragmentation experiments. Furthermore, it is
well known that a number of peptides are difficult to frag-
ment in (LC-)MS/MS experiments. If an accurate instru-
ment is used (e.g., Orbitrap or Q-TOF), it would be
possible to extract suggestions for modifications from the
survey scans, which could be the basis of alternative exper-
iments (the use of other proteases, introduced chemical
modifications, site-directed mutations in recombinant
proteins, etc.).
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